Trying to Understand Differing Results of FIRE-3 and 80405: Does the First Treatment Matter More Than Others?

J Clin Oncol. 2015 Nov 10;33(32):3686-8. doi: 10.1200/JCO.2015.62.8495. Epub 2015 Aug 31.

Authors

Bert H O'Neil¹, Alan P Venook²

Affiliations

¹ Indiana University Simon Cancer Center, Indianapolis, IN.
² University of California, San Francisco, San Francisco, CA alan.venook@ucsf.edu.

PMID: 26324365
DOI: 10.1200/JCO.2015.62.8495

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Colorectal Neoplasms / drug therapy*
Female
Humans
Male
Proto-Oncogene Proteins / genetics*
ras Proteins / genetics*

Substances

Proto-Oncogene Proteins
ras Proteins